FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D Pharmacy Times
2026
Edwards wins FDA approval for tricuspid valve repair device
Edwards wins FDA approval for tricuspid valve repair device MedTech Dive
FDA Approves Subcutaneous Induction for Skyrizi in Crohn’s Disease
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease Pharmaceutical Executive
FDA Approves Subcutaneous Risankizumab Induction for Crohn’s Disease
FDA Approves Subcutaneous Risankizumab Induction for Crohn’s Disease HCPLive